1st Quarter - Report

ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.) for ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$680,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Feb 15, 2021 $680,000 Replaced
1st Quarter - Amendment Apr 20, 2021 $560,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education;Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home HealthCare Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Telehealth/Digital Health; Surprise Billing; Anti-Kickback Statute Reform; CREATES Act; COVID-19; Value in Health Care Act

LobbyistCovered position, as disclosed
MEGHAN CLUNE WOLTMAN New —
ANTHONY CURRY —
JILL DOWELL - EFFECTIVE 2/9/21 —
THOMAS MCDANIELS —
JOYCE ROGERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education;Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home HealthCare Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Telehealth/Digital Health; Surprise Billing; Anti-Kickback Statute Reform; CREATES Act; COVID-19; Value in Health Care Act

LobbyistCovered position, as disclosed
MEGHAN CLUNE WOLTMAN New —
ANTHONY CURRY —
JILL DOWELL - EFFECTIVE 2/9/21 —
THOMAS MCDANIELS —
JOYCE ROGERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.